Bridgebio Oncology TherapeutBBOT
13F holders, Q1 2024 (March 31)29holders
3famous investors
$10.39avg. 13F price*
At the end of Q1 2024, 29 institutions reported holding Bridgebio Oncology Therapeut (BBOT) in their 13F filings. The largest holders were Cormorant Asset Management, LP ($30.3M), BlackRock Inc. ($15.6M) and Adage Capital Partners Gp, L.L.C. ($14.6M). 3 famous investors held it, including George Soros (0.2% of Soros Fund Management's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Bridgebio Oncology Therapeut
- Filed as
- HELIX ACQUISITION CORP II (Q1 2024)
- CUSIP
- G4444H101
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 30 | $166.9M |
| Exits | 0 | $0 |
Ownership 29 holders
| Cormorant Asset Management, LP | 1.33% | New | 2,909,000 | $30.3M |
| BlackRock Inc. | 0.00% | New | 1,500,000 | $15.6M |
| Adage Capital Partners Gp, L.L.C. | 0.03% | New | 1,400,000 | $14.6M |
| Citadel Advisors | 0.01% | New | 1,332,453 | $13.8M |
| T. Rowe Price Associates Inc. | 0.00% | New | 1,130,677 | $11.7M |
| Millennium Management | 0.01% | New | 1,105,790 | $11.5M |
| Sculptor Capital LP | 0.23% | New | 705,000 | $7.3M |
| Farallon Capital Management, L.L.C. | 0.04% | New | 600,000 | $6.2M |
| Silverarc Capital Management, LLC | 1.46% | New | 500,000 | $5.2M |
| Great Point Partners LLC | 0.81% | New | 500,000 | $5.2M |
| Commodore Capital LP | 0.35% | New | 500,000 | $5.2M |
| Perceptive Advisors LLC | 0.09% | New | 500,000 | $5.2M |
| Soros Fund Management | 0.19% | New | 475,000 | $4.9M |
| ADAR1 Capital Management, LLC | 1.15% | New | 403,500 | $4.2M |
| T. Rowe Price Investment Management, Inc. | 0.00% | New | 400,000 | $4.1M |
| Ghost Tree Capital, LLC | 1.00% | New | 300,000 | $3.1M |
| Laurion Capital Management LP | 0.09% | New | 300,000 | $3.1M |
| Affinity Asset Advisors, LLC | 0.45% | New | 250,000 | $2.6M |
| Octagon Capital Advisors LP | 0.31% | New | 250,000 | $2.6M |
| Wellington Management Group LLP | 0.00% | New | 202,160 | $2.1M |
| Stempoint Capital LP | 0.56% | New | 200,000 | $2.1M |
| Two Sigma Investments, LP | 0.01% | New | 189,285 | $2.0M |
| Woodline Partners LP | 0.01% | New | 106,705 | $1.1M |
| Moore Capital Management, LP | 0.02% | New | 100,000 | $1.0M |
| Walleye Capital LLC | 0.01% | New | 92,224 | $955K |
| Cowen and Company, LLC | 0.02% | New | 54,413 | $566K |
| Walleye Trading LLC | 0.01% | New | 51,876 | $537K |
| Geode Capital Management, LLC | 0.00% | New | 10,869 | $112K |
| JPMorgan Chase & Co. | 0.00% | New | 4 | $41 |
"% of holder's portfolio" is BBOT's weight in each manager's 13F, not the share of Bridgebio Oncology Therapeut the manager owns.